Health 4 Brands launched in the UK

September 11, 2009
Medical Communications Euro RSCG, advertising

Euro RSCG Life has launched Health 4 Brands as a second health agency in the UK. Health 4 Brands (H4B) …

Contract manufacturing news in brief

September 11, 2009
Manufacturing and Production

Newsflow in the contract manufacturing sector is picking up again as the summer draws to a close, with new agreements …

Biotech suffers as recession hits

September 11, 2009
Medical Communications biotech, intercytex

 The fears of many biotech leaders are being realised, as a string of small-scale companies face liquidation at the hands …

Roche divests protein expression portfolio

September 10, 2009
Research and Development Roche, genomics

 Roche has sold its cell-free protein expression kits business for an undisclosed sum.Berlin-based company RiNA will take control of the …

Cipla plans push into biosimilars

September 10, 2009
Sales and Marketing biosimilars, generics

Mumbai-based generics manufacturer Cipla is to begin making biosimilars, generic substitutable versions of branded biologic drugs. It plans to do …

Industry cautions over probe into use of NICE approved drugs

September 10, 2009
Sales and Marketing NICE, hc

The UK pharma industry has urged caution over data collected on the use of NICE-approved drugs on the NHS that …

Careers Voice: Making training work

September 10, 2009
Business Services careers, careers voice, training

A senior manager in a major pharmaceutical company told me that the industry spends millions on training and next to …

Expanding clinical trials in India: answering the need for training

September 8, 2009
Research and Development India, clinical trials

 India is widely seen as the most exciting country in the clinical research world. Its potential to deliver large numbers …

Herceptin scientist wins Janssen award for biomedical research

September 8, 2009
Research and Development Herceptin, Janssen

Johnson & Johnson has honoured the career achievements of Axel Ullrich by awarding him with the 2009 Dr Paul Janssen …

Observational studies will help answer growing safety demands

September 8, 2009
Research and Development ICON, drug safety

The pharmaceutical industry is ready to adapt to growing drug safety requirements, but understanding of how it can capture safety …

OnMedica merges with MedSci

September 7, 2009
Medical Communications, Sales and Marketing OnMedica, digi

Online PR company and medical education provider OnMedica Group has merged with medical communications company MedSci.The combined says it will …

Patients on Enbrel work longer, says study

September 7, 2009
Research and Development, Sales and Marketing Enbrel, RA

 Rheumatoid arthritis patients taking Enbrel are able to keep working for longer, according to a new study comparing its affects …

Blow for Irish pharma sector as Teva, Elan cut staff

September 7, 2009
Manufacturing and Production Elan, Teva, lilly

Ireland’s pharmaceutical sector suffered a double blow last week as two drugmakers opted to make staff redundant at manufacturing plants …

NICE backs limited use of Lilly’s Plavix rival

September 7, 2009
Research and Development Efient, NICE

 NICE has recommended Lilly and Daiichi’s Efient for use on the NHS, giving the blood-thinner drug a boost in its …

Roche and PTC sign CNS research deal

September 4, 2009
Research and Development CNS, Roche

 PTC Therapeutics has signed an early-stage drug discovery deal with Roche that will focus on treatments for central nervous system …

Cameron: Tories are ‘the party of the NHS’

September 4, 2009
NHS, US

David Cameron has called the Conservatives the "party of the NHS," in an attempt to reassure voters the service is …

Head-to-head boost for Brilinta over Plavix

September 4, 2009
Research and Development, Sales and Marketing AZ, Brillinta

 AstraZeneca has released details of its brand Brilinta’s performance in head-to-head trials with Plavix, the world’s second biggest-selling drug.Earlier this …

Roche’s MabThera expands licence in leukaemia

September 4, 2009
Research and Development, Sales and Marketing MabThera, Roche

 MabThera has been approved in Europe for use in previously treated chronic lymphocytic leukaemia, which Roche says will offer new …

The Gateway to Local Adoption Series

Latest content